ALLR Stock Analysis: Buy, Sell, or Hold?
ALLR - Allarity Therapeutics, Inc. Common Stock
$1.35
-0.16 (-10.60%)
▼
5d:
-12.9%
30d:
+8.87%
90d:
+59.74%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When ALLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called ALLR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALLR is down 12.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ALLR is down 12.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALLR is currently trading at $1.35, which is considered fair relative to its 30-day fair value range of $1.24 to $1.49.
Technical Outlook: Technically, ALLR is in a uptrend. Immediate support is located at $1.24, while resistance sits at $1.72. Short-term momentum is weak, with the stock down 10.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.75 (+622.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALLR is in a uptrend. Immediate support is located at $1.24, while resistance sits at $1.72. Short-term momentum is weak, with the stock down 10.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.75 (+622.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.24 -
$1.49
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.6%)
- BULLISH: Trading 622.2% below Wall St target ($9.75)
- WARNING: Recommendation downgraded due to -12.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.24 -
$1.49
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.24
Resistance Level
$1.72
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.39
Wall Street Target
$9.75
(+622.2%)
Share & Embed Analysis
Last updated: May 18, 2026 7:53 AM ET
Data refreshes hourly during market hours. Next update: 8:53 AM
Data refreshes hourly during market hours. Next update: 8:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 64 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 61 BUY |
